2.48
2.48%
0.06
アフターアワーズ:
2.48
前日終値:
$2.42
開ける:
$2.45
24時間の取引高:
56,888
Relative Volume:
0.40
時価総額:
$22.69M
収益:
$2.05M
当期純損益:
$-27.28M
株価収益率:
-0.4306
EPS:
-5.76
ネットキャッシュフロー:
$-18.89M
1週間 パフォーマンス:
+7.36%
1か月 パフォーマンス:
+13.24%
6か月 パフォーマンス:
+15.89%
1年 パフォーマンス:
+78.42%
iBio Inc Stock (IBIO) Company Profile
IBIO を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
IBIO
iBio Inc
|
2.48 | 22.69M | 2.05M | -27.28M | -18.89M | -15.02 |
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-05-28 | 開始されました | Chardan Capital Markets | Buy |
2021-11-29 | 開始されました | JMP Securities | Mkt Outperform |
2021-01-22 | 開始されました | Cantor Fitzgerald | Overweight |
2020-06-26 | 開始されました | Alliance Global Partners | Buy |
iBio Inc (IBIO) 最新ニュース
iBio Inc. stock rises Thursday, outperforms market - MarketWatch
iBio Inc. stock falls Wednesday, still outperforms market - MarketWatch
LUCID CAPITAL MARKETS Initiates Coverage of iBio (IBIO) with Buy Recommendation - MSN
iBio Inc. stock rises Tuesday, outperforms market - MarketWatch
iBio Inc. stock rises Monday, outperforms market - MarketWatch
Chardan Capital Initiates Coverage of iBio (IBIO) with Buy Recommendation - MSN
iBio Inc. stock falls Friday, underperforms market - MarketWatch
iBio Inc. stock falls Thursday, underperforms market - MarketWatch
iBio Inc. stock falls Wednesday, underperforms market - MarketWatch
iBio Inc. stock falls Tuesday, underperforms market - MarketWatch
iBio Inc. stock outperforms market despite losses on the day - MarketWatch
iBio Inc. stock rises Friday, outperforms market - MarketWatch
iBio Inc. stock rises Wednesday, outperforms market - MarketWatch
iBio Inc. stock falls Monday, underperforms market - MarketWatch
iBio Strengthens Board with Appointment of Two New Independent Directors - GlobeNewswire
iBio Strengthens Board with Key Appointments in Finance, Antibody Discovery - StockTitan
Ikarian Capital, LLC Adjusts Stake in iBio Inc - GuruFocus.com
ADAR1 Capital Management's Strategic Acquisition in iBio Inc - GuruFocus.com
iBio Inc Reports Fiscal Q1 GAAP EPS of -$0.52, Missing Estimates; No Revenue Reported, Aligning with Expectations - GuruFocus.com
iBio Reports Fiscal First Quarter 2025 Financial Results - GlobeNewswire
iBio (NYSE:IBIO) Trading Down 0.6% – Here’s What Happened - Defense World
iBio Inc. stock remains steady Monday, underperforms market - MarketWatch
iBio Unveils AI-Driven Antibody Discovery Strategy - TipRanks
Plant-Based Vaccines Market Is Booming Worldwide 2024-2031 | - openPR
iBio Inc. stock remains steady Thursday, underperforms market - MarketWatch
iBio Inc (IBIO) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):